- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03885609
Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study includes 84 treatment sessions, twice a day, and 4 clinic visits over a period of 6 weeks.
One treatment group (Silk'n power toothbrush - ToothWave) and 1 control group (an ADA approved power toothbrush (PTB)) will participate in the study.
For each patient, efficacy assessment data will be collected at baseline, 4 weeks, and at 6 weeks. The average stain data will be calculated for each group.
Treatment is defined as a timed, 2 minute brushing of the teeth according to the manufactur-er's instructions, twice daily (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard fluoride toothpaste. The control group will use an ADA ac-cepted PTB and the same standard fluoride toothpaste.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46825
- Salus Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult subjects aged 18-70, that are in good health.
- Subjects should have notable extrinsic dental stains on the front teeth with a total extrin-sic facial tooth stain score ≥14 according to the LSI.
- The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
- The subjects should be willing to comply with the study procedure and schedule, includ-ing the follow up visits, and will refrain from using any other teeth whitening technologies during this period.
- The subject did not perform any procedure for teeth whitening (either at home or in clin-ic) at least 3 years prior to participating in the study
Exclusion Criteria:
- Any condition that might make it unsafe for the subject to participate in the study, at the discretion of the investigator
- Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
- Pregnant or nursing by subject report.
- Any active condition in the oral cavity at the discretion of the investigator.
- Any surgery in the treated area within 3 months prior to treatment, or before complete healing.
- Subjects that do not brush regularly.
- Regular tobacco smokers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment - toothwave brush
Subjects using the Silk'n ToothWave RF utilizing toothbrush
|
RF-utilizing powered toothbrush for teeth whitening
Other Names:
|
Sham Comparator: Control - powered toothbrush
Subject using a regular powered toothbrush with no RF.
|
regular powered toothbrush with no RF
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Extrinsic Stains
Time Frame: 6 weeks
|
Extrinsic Stains will be evaluated using the validated Lobene Stain Index (LSI) Stain Intensity score range is between 0 and 3, where: 0 = no stain
The mean stain intensity will be calculated for both the gingival and body regions of the incisor teeth for each subject. Stain Area score rage is between 0 and 3, where: 0 = no stain
The mean stain area will be calculated for both the gingival and body regions of the incisor teeth for each subject. |
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tooth color assessment
Time Frame: 6 weeks
|
VITA Bleachedguide 3D-Master shade guide, includes 29 shade levels defined by the American Dental Association (ADA).
These shade levels represents the brightness of the tooth where 1 is the whitest and 29 is the darkest shade.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeffery L Milleman, DDS, MPA, Salus research center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DO116028A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Discoloration
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityUnknownDiscoloration, Tooth
-
Cairo UniversityNot yet recruitingDiscoloration, Tooth | Abrasion
-
Technische Universität DresdenCompletedDiscoloration of TeethGermany
-
Aristotle University Of ThessalonikiCompleted
-
Cairo UniversityChildren's Cancer Hospital Egypt 57357RecruitingDiscoloration, Tooth | Secondary Caries | Fracture ToothEgypt
-
Cairo UniversityRecruitingDiscoloration, Tooth | Chip Tooth | Non Vital Teeth | Trauma DentalEgypt
Clinical Trials on ToothWave
-
Rambam Health Care CampusCompleted
-
Home Skinovations Ltd.CompletedGingivitis | Plaque | Tooth Discoloration | CalculusUnited States
-
Home Skinovations Ltd.CompletedTooth DiscolorationUnited States